Consequently, patients often find that their appetite suppression is much stronger and more reliable at higher doses compared to the first month of treatment
However, its active ingredient, semaglutide, is also present in Wegovy, the GLP-1 medication FDA-approved for weight loss, and available as a compounded medication
This typically means: Proof of type 2 diabetes diagnosis Documentation showing youve tried first-line medications (like metformin) Clinical justification for Mounjaro specifically Diabetes vs
Estimated average energy requirements are approximately 2,000 kcal/day for women and 2,500 kcal/day for men, with the NHS 12-week Weight Loss Plan recommending reduced targets of around 1,400 kcal/day for women and 1,900 kcal/day for men to create a sustainable deficit